GAB4
gene geneOn this page
Summary
GAB4 (GRB2 associated binding protein family member 4, HGNC:18325) is a protein-coding gene on chromosome 22q11.1, encoding GRB2-associated-binding protein 4 (Q2WGN9).
Predicted to enable transmembrane receptor protein tyrosine kinase adaptor activity. Predicted to be involved in signal transduction. Predicted to be active in cytoplasm.
Source: NCBI Gene 128954 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 107 total
- Dosage sensitivity (ClinGen): haploinsufficiency dosage sensitivity unlikely, triplosensitivity no evidence
- MANE Select transcript:
NM_001037814
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18325 |
| Approved symbol | GAB4 |
| Name | GRB2 associated binding protein family member 4 |
| Location | 22q11.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000215568 |
| Ensembl biotype | protein_coding |
| Entrez | 128954 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 2 protein_coding, 2 nonsense_mediated_decay, 2 protein_coding_CDS_not_defined
ENST00000400588, ENST00000465611, ENST00000520505, ENST00000523144, ENST00000643316, ENST00000651146
RefSeq mRNA: 2 — MANE Select: NM_001037814
NM_001037814, NM_001366857
CCDS: CCDS42976
Canonical transcript exons
ENST00000400588 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001543665 | 16961936 | 16962876 |
| ENSE00001543672 | 16966100 | 16966364 |
| ENSE00001543676 | 16969943 | 16970193 |
| ENSE00001543677 | 16987960 | 16988167 |
| ENSE00001543684 | 17007941 | 17008222 |
| ENSE00003465094 | 16965178 | 16965268 |
| ENSE00003541852 | 16963725 | 16963829 |
| ENSE00003567406 | 16964766 | 16964862 |
| ENSE00003654045 | 16968298 | 16968383 |
| ENSE00003670539 | 16991873 | 16992176 |
Expression profiles
Bgee: expression breadth broad, 52 present calls, max score 81.89.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0296 / max 17.5923, expressed in 9 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 193062 | 0.0296 | 9 |
Top tissues by expression
225 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.89 | gold quality |
| left testis | UBERON:0004533 | 64.77 | gold quality |
| right testis | UBERON:0004534 | 64.02 | gold quality |
| testis | UBERON:0000473 | 63.30 | gold quality |
| sural nerve | UBERON:0015488 | 63.20 | silver quality |
| myocardium | UBERON:0002349 | 53.86 | gold quality |
| tibial nerve | UBERON:0001323 | 49.24 | gold quality |
| colonic epithelium | UBERON:0000397 | 48.86 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 47.83 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 46.13 | gold quality |
| adult organism | UBERON:0007023 | 45.99 | gold quality |
| spinal cord | UBERON:0002240 | 45.55 | gold quality |
| buccal mucosa cell | CL:0002336 | 45.37 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| vastus lateralis | UBERON:0001379 | 41.41 | gold quality |
| quadriceps femoris | UBERON:0001377 | 41.37 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
| substantia nigra | UBERON:0002038 | 41.30 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 41.10 | gold quality |
| midbrain | UBERON:0001891 | 41.08 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 41.06 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 40.98 | gold quality |
| amniotic fluid | UBERON:0000173 | 40.69 | gold quality |
| jejunal mucosa | UBERON:0000399 | 40.59 | gold quality |
| biceps brachii | UBERON:0001507 | 40.57 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 40.45 | gold quality |
| gingival epithelium | UBERON:0001949 | 40.43 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 40.33 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 40.27 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.11 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
32 targeting GAB4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-124-3P | 99.89 | 73.74 | 3043 |
| HSA-MIR-506-3P | 99.89 | 73.55 | 3057 |
| HSA-MIR-7162-3P | 99.89 | 68.16 | 1682 |
| HSA-MIR-7110-5P | 99.80 | 67.84 | 1712 |
| HSA-MIR-6842-5P | 99.80 | 67.54 | 1587 |
| HSA-MIR-4690-5P | 99.65 | 66.24 | 813 |
| HSA-MIR-6752-5P | 99.59 | 67.32 | 1243 |
| HSA-MIR-4649-3P | 99.56 | 66.90 | 1783 |
| HSA-MIR-3171 | 99.49 | 69.06 | 776 |
| HSA-MIR-103A-1-5P | 99.39 | 67.78 | 1545 |
| HSA-MIR-103A-2-5P | 99.39 | 67.72 | 1577 |
| HSA-MIR-622 | 98.99 | 66.48 | 1050 |
| HSA-MIR-320A-5P | 98.88 | 66.75 | 1248 |
| HSA-MIR-4751 | 98.80 | 64.95 | 525 |
| HSA-MIR-423-5P | 98.69 | 67.48 | 1522 |
| HSA-MIR-6731-3P | 98.61 | 67.86 | 749 |
| HSA-MIR-3184-5P | 98.56 | 67.13 | 1491 |
| HSA-MIR-6827-5P | 98.46 | 64.88 | 1256 |
| HSA-MIR-6764-3P | 98.44 | 67.64 | 1153 |
| HSA-MIR-6824-3P | 98.44 | 67.62 | 1154 |
| HSA-MIR-1265 | 98.36 | 66.46 | 598 |
| HSA-MIR-595 | 98.25 | 67.44 | 699 |
| HSA-MIR-3144-5P | 97.64 | 65.45 | 646 |
| HSA-MIR-296-5P | 97.61 | 64.02 | 851 |
| HSA-MIR-6131 | 97.22 | 66.72 | 960 |
| HSA-MIR-4732-3P | 97.15 | 65.45 | 881 |
| HSA-MIR-4474-3P | 96.97 | 65.87 | 870 |
| HSA-MIR-4693-3P | 95.23 | 65.92 | 735 |
| HSA-MIR-4268 | 94.45 | 64.09 | 819 |
Functional genomics
ClinGen dosage: haploinsufficiency 40 (dosage sensitivity unlikely), triplosensitivity 0 (no evidence). ClinGen Gene Dosage Map
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| drosophila_melanogaster | dos | FBGN0016794 |
| caenorhabditis_elegans | WBGENE00004928 |
Paralogs (7): PHLDB1 (ENSG00000019144), GAB2 (ENSG00000033327), GAB1 (ENSG00000109458), PHLDB2 (ENSG00000144824), PLEKHS1 (ENSG00000148735), GAB3 (ENSG00000160219), PHLDB3 (ENSG00000176531)
Protein
Protein identifiers
GRB2-associated-binding protein 4 — Q2WGN9 (reviewed: Q2WGN9)
Alternative names: GRB2-associated binder 2-like, GRB2-associated binder 4, GRB2-associated-binding protein 2-like, Growth factor receptor bound protein 2-associated protein 4
All UniProt accessions (4): Q2WGN9, A0A2R8Y714, A0A494C132, H0YB31
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the GAB family.
RefSeq proteins (2): NP_001032903, NP_001353786 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001849 | PH_domain | Domain |
| IPR011993 | PH-like_dom_sf | Homologous_superfamily |
| IPR046355 | Gab1-4-like | Family |
Pfam: PF00169
UniProt features (13 total): compositionally biased region 5, region of interest 5, chain 1, domain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q2WGN9-F1 | 54.53 | 0.12 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 20 (showing top):
GOMF_SIGNALING_RECEPTOR_BINDING, GOBP_CELL_SURFACE_RECEPTOR_PROTEIN_TYROSINE_KINASE_SIGNALING_PATHWAY, GOMF_KINASE_BINDING, GOMF_SIGNALING_RECEPTOR_COMPLEX_ADAPTOR_ACTIVITY, GOMF_PROTEIN_TYROSINE_KINASE_BINDING, GOMF_SIGNALING_ADAPTOR_ACTIVITY, CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ADAPTOR_ACTIVITY, GOMF_RECEPTOR_TYROSINE_KINASE_BINDING, GOBP_ENZYME_LINKED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY, MIR6827_5P, MIR595, MIR4751, GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_DN
GO Biological Process (2): signal transduction (GO:0007165), cell surface receptor protein tyrosine kinase signaling pathway (GO:0007169)
GO Molecular Function (1): transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068)
GO Cellular Component (1): cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| enzyme-linked receptor protein signaling pathway | 1 |
| cell surface receptor protein tyrosine kinase signaling pathway | 1 |
| signaling receptor complex adaptor activity | 1 |
| receptor tyrosine kinase binding | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
194 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GAB4 | LRRC74B | Q6ZQY2 | 548 |
| GAB4 | RIMBP3C | A6NJZ7 | 530 |
| GAB4 | CCT8L2 | Q96SF2 | 517 |
| GAB4 | GRB2 | P29354 | 503 |
| GAB4 | C2CD4D | B7Z1M9 | 479 |
| GAB4 | OR2B11 | Q5JQS5 | 433 |
| GAB4 | ZSCAN30 | Q86W11 | 431 |
| GAB4 | A1BG | P04217 | 399 |
| GAB4 | MTNAP1 | Q9BSJ5 | 392 |
| GAB4 | CRKL | P46109 | 380 |
| GAB4 | LRRC74A | Q0VAA2 | 350 |
| GAB4 | DCAF4L2 | Q8NA75 | 348 |
| GAB4 | PTPN11 | Q06124 | 338 |
| GAB4 | CD28 | P10747 | 333 |
| GAB4 | GAB2 | Q9UQC2 | 322 |
IntAct
0 interactions, top by confidence:
BioGRID (1): GAB4 (Affinity Capture-MS)
ESM2 similar proteins: A0JPN4, A6NP61, A8MVX0, B2RQL2, D2J0Y4, E9Q2Z1, O35181, O43734, O88286, O88850, P0DW16, P28322, P43268, P56975, P86174, P97303, Q01954, Q1W617, Q1XFL1, Q2WGN9, Q3TQ03, Q3USH1, Q498S6, Q4G112, Q4V7B1, Q5D1E7, Q69ZB8, Q6A098, Q6ZU67, Q6ZVD7, Q76N89, Q7Z7G1, Q8BIY3, Q8BW86, Q8IUC6, Q8K4P8, Q8N365, Q8N7N6, Q8NA82, Q93075
Diamond homologs: A6QLU3, Q00IB7, Q13480, Q2WGN9, Q86SQ0, Q8BUL6, Q8K1N2, Q8WWW8, Q99PF6, Q9EQH1, Q9HB21, Q9QYY0, Q9ULM0, Q9UQC2, Q9VZZ9, Q9W5D0, Q9Z1S8, Q3ZBA3, Q86IV4, Q8BSM5, Q9ERS5, Q9HB19, P54644, Q1ZXL0, Q559T8, Q55GV3, Q5U2Z7, Q6Q308, Q8C115, Q8C2K1, Q8IVE3, Q8N264, Q9NYT0, Q9QXT1, Q9ST43, Q9UN19, Q9WV52, A8JQ65, B4I4Y1, B4PRE2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
107 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 97 |
| Likely benign | 9 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2192 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 22:16965175:CA:C | donor_loss | 1.0000 |
| 22:16965176:ACCT:A | donor_loss | 1.0000 |
| 22:16965264:GTTGG:G | acceptor_gain | 1.0000 |
| 22:16965265:TTGG:T | acceptor_gain | 1.0000 |
| 22:16965266:TGG:T | acceptor_gain | 1.0000 |
| 22:16965267:GG:G | acceptor_gain | 1.0000 |
| 22:16965267:GGC:G | acceptor_loss | 1.0000 |
| 22:16965269:C:CC | acceptor_gain | 1.0000 |
| 22:16965269:C:G | acceptor_loss | 1.0000 |
| 22:16965275:C:CT | acceptor_gain | 1.0000 |
| 22:16965276:A:T | acceptor_gain | 1.0000 |
| 22:16991973:A:AC | donor_gain | 1.0000 |
| 22:16991974:C:CC | donor_gain | 1.0000 |
| 22:16991974:CTGGT:C | donor_gain | 1.0000 |
| 22:16991994:ATAGC:A | donor_gain | 1.0000 |
| 22:17007939:A:AC | donor_gain | 1.0000 |
| 22:17007940:C:CC | donor_gain | 1.0000 |
| 22:17007940:CA:C | donor_gain | 1.0000 |
| 22:17007940:CAAAG:C | donor_gain | 1.0000 |
| 22:17007943:AGAG:A | donor_gain | 1.0000 |
| 22:17007952:G:C | donor_gain | 1.0000 |
| 22:17007955:T:TA | donor_gain | 1.0000 |
| 22:17007973:T:TA | donor_gain | 1.0000 |
| 22:16962872:GATGG:G | acceptor_gain | 0.9900 |
| 22:16962873:ATGG:A | acceptor_gain | 0.9900 |
| 22:16962874:TGG:T | acceptor_gain | 0.9900 |
| 22:16962875:GG:G | acceptor_gain | 0.9900 |
| 22:16962877:C:CC | acceptor_gain | 0.9900 |
| 22:16962877:C:CG | acceptor_loss | 0.9900 |
| 22:16963803:G:T | acceptor_gain | 0.9900 |
AlphaMissense
3790 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 22:16991922:C:A | W143C | 0.999 |
| 22:16991922:C:G | W143C | 0.999 |
| 22:16991924:A:G | W143R | 0.999 |
| 22:16991924:A:T | W143R | 0.999 |
| 22:16991961:A:C | F130L | 0.999 |
| 22:16991961:A:T | F130L | 0.999 |
| 22:16991963:A:G | F130L | 0.999 |
| 22:16992156:A:C | F65L | 0.999 |
| 22:16992156:A:T | F65L | 0.999 |
| 22:16992157:A:G | F65S | 0.999 |
| 22:16992158:A:G | F65L | 0.999 |
| 22:16991956:A:G | L132P | 0.998 |
| 22:16991988:A:C | F121L | 0.998 |
| 22:16991988:A:T | F121L | 0.998 |
| 22:16991989:A:G | F121S | 0.998 |
| 22:16991990:A:G | F121L | 0.998 |
| 22:16992110:A:G | Y81H | 0.998 |
| 22:16992171:C:A | W60C | 0.998 |
| 22:16992171:C:G | W60C | 0.998 |
| 22:16992173:A:G | W60R | 0.998 |
| 22:16992173:A:T | W60R | 0.998 |
| 22:16991923:C:G | W143S | 0.997 |
| 22:16992115:A:G | L79P | 0.997 |
| 22:16992161:A:G | W64R | 0.997 |
| 22:16992161:A:T | W64R | 0.997 |
| 22:16991950:G:T | A134D | 0.996 |
| 22:16991962:A:G | F130S | 0.996 |
| 22:16991989:A:C | F121C | 0.995 |
| 22:16992070:A:C | I94S | 0.995 |
| 22:16992070:A:T | I94N | 0.995 |
dbSNP variants (sampled 300 via entrez): RS1000020296 (22:16998850 G>C,T), RS1000247177 (22:16987277 C>T), RS1000274392 (22:16992552 C>T), RS1000383515 (22:16986922 C>T), RS1000445814 (22:16992952 C>T), RS1000533206 (22:17004714 A>T), RS1000636848 (22:17009011 C>T), RS1000650318 (22:16974496 G>A), RS1000725758 (22:16980400 G>T), RS1000748512 (22:16974104 G>A), RS1001113293 (22:17003442 C>G,T), RS1001255715 (22:16985710 A>G), RS1001294990 (22:16978793 G>A), RS1001355104 (22:16997822 A>G), RS1001369601 (22:16991382 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Phthalic Acids | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.